Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

GRCE US Equity

Grace Therapeutics, Inc.Health Care · Pharmaceutical Preparations · CIK 1444192 · FY ends Mar 31
$2.20
+0.07 (+3.29%)
USD · as of 2026-08-19 · marketstack
3 8-K filings · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by ADAR1 Capital Management, LLCsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Nantahala Capital Management, LLCsec.gov ↗
2026-08-138-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-0713GSchedule 13G filed — ≥5% beneficial owner (passive) · by Opaleye Management Inc.sec.gov ↗
2026-08-068-K 8.01Other eventssec.gov ↗
2026-08-068-K 3.02Unregistered sales of equity securitiessec.gov ↗
2026-08-068-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-07-288-K 8.01Other eventssec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-28

Every row is a filed document, checked against its EDGAR index.